UHS Q1 2024 Earnings Report
Key Takeaways
Universal Health Services, Inc. reported a strong first quarter in 2024, with net income attributable to UHS reaching $261.8 million, or $3.82 per diluted share, compared to $163.1 million, or $2.28 per diluted share, in the first quarter of 2023. Net revenues also saw a substantial increase of 10.8% to $3.844 billion.
Net income attributable to UHS was $261.8 million, or $3.82 per diluted share.
Net revenues increased by 10.8% to $3.844 billion.
Adjusted net income attributable to UHS was $253.1 million, or $3.70 per diluted share.
Net cash provided by operating activities was $396 million.
UHS
UHS
UHS Revenue by Segment
Forward Guidance
This press release contains forward-looking statements based on current management expectations. Numerous factors, including those disclosed herein, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 1A-Risk Factors, and Item 7-Forward-Looking Statements and Risk Factors, in our Form 10-K for the year ended December 31, 2023), may cause the results to differ materially from those anticipated in the forward-looking statements.
Positive Outlook
- UHS has built an impressive record of achievement and performance.
- UHS ranked #311 on the Fortune 500; and #434 on Forbes’ list of America’s Largest Public Companies
- UHS was again recognized as one of the World’s Most Admired Companies by Fortune.
- Our operating philosophy is as effective today as it was upon the Company’s founding in 1979, enabling us to provide compassionate care to our patients and their loved ones.
- Our strategy includes building or acquiring high quality hospitals in rapidly growing markets, investing in the people and equipment needed to allow each facility to thrive, and becoming the leading healthcare provider in each community we serve.
Challenges Ahead
- A significant portion of our revenues are derived from federal and state government programs including the Medicare and Medicaid programs.
- The increase in interest rates has substantially increased our borrowings costs and reduced our ability to access the capital markets on favorable terms.
- The outcome of known and unknown litigation, liabilities and other claims asserted against us and/or our subsidiaries, including, but not limited to, the March 28, 2024, jury award (of compensatory damages of $60 million and punitive damages of $475 million) against The Pavilion Behavioral Health System
- Payments from these programs are subject to statutory and regulatory changes, administrative rulings, interpretations and determinations, requirements for utilization review, and federal and state funding restrictions.
- Additional increases in interest rates could have a significant unfavorable impact on our future results of operations and the resulting effect on the capital markets could adversely affect our ability to carry out our strategy.
Revenue & Expenses
Visualization of income flow from segment revenue to net income